Randomized trial demonstrates enhanced biomarker detection in biosensing, indicating improved diagnostic potential.
Noninvasive detection of ultra-weak biomagnetic signals is crucial for modern biosensing, but conventional magnetic sensors are fundamentally limited by intrinsic noise. Orthogonal fluxgates (OFGs) enable high signal-to-noise-ratio detection of weak magnetic fields, yet their performance is still constrained by intrinsic 1/f noise and Barkhausen-related magnetic fluctuations. This study reports a low-noise orthogonal fluxgate in which a newly designed magnetic core and circuit mitigate existing noise limitations. The CoP/Ag composite core, featuring an amorphous-nanocrystalline dual phase, is associated with reduced low-frequency magnetic loss and improved noise performance. When integrated with a closed-loop feedback, the sensor achieves a noise floor of 8 pT/√Hz at 1 Hz. The sensor enables reliable detection of ultralow-concentration magnetic-bead signals. Alpha-fetoprotein (AFP) was used as a model biomarker in an immunomagnetic bead assay, yielding a linear response from 50 fg mL −1 to 100 ng mL −1 and a detection limit of 50 fg mL −1 , which compares favorably with representative reported AFP magnetic biosensors. OFGs demonstrate strong prospects in biosensing, geomagnetic measurements, and weak field detection.
No takes yet. Share an insight, caveat, or question.
Pu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: